Cleave Therapeutics
Dina Gonzalez is a consultant providing financial and administrative services primarily to venture-backed start-up companies. Ms. Gonzalez specializes in life science companies, but her career has spanned 20 years in the finance industry, starting as a cost accountant in the semiconductor industry. She has held positions of increasing responsibility at VLSI Technology, Philips Semiconductors, Cerexa (acquired by Forest Laboratories), Corthera (acquired by Novartis) and Adynxx (reverse merger with Alliqua BioMedical).
Ms. Gonzalez obtained her MBA from St. Mary’s University, San Antonio, Texas. She also holds a BBA in Accounting from St. Mary’s University, San Antonio, Texas and her MPA in Accounting from the University of Texas at San Antonio.
This person is not in the org chart
This person is not in any offices
Cleave Therapeutics
Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.